Drug offers hope to neck and head cancer sufferers

An immunotherapy drug could soon offer hope to patients with currently untreatable head and neck cancers.
Nivolumab was hailed a potential game-changer after it was found to extend the lives of relapsed patients who had run out of therapy options.